Canadian Prime Minister Justin Trudeau gave the green light in mid-May last year to collaborate with China’s KangXinuo Biological Company to develop a vaccine and approved the start of clinical trials there, only to announce a few days later that the collaboration had collapsed.
An investigation report submitted to Canada‘s parliament recently pointed out that the Chinese government prevented vaccine samples from being shipped to Canada as the reason for the termination of the cooperation, which experts believe is related to the extradition case of Meng Wanzhou, the crown prince of Chinese science company huawei.
The Canadian media reported Tuesday (26) that the parliamentary report revealed that Chinese customs seized a shipment of “Ad5-nCoV” vaccine samples bound for Canada at Beijing Capital International Airport on May 19 last year. The delayed shipment caused authorities to lose interest in the vaccine’s development and, along with good progress on other Chinese communist virus vaccines, Canada halted cooperation between the two countries in late August and focused on developing other vaccine candidates.
Margaret McCuaig-Johnston, a former senior Canadian government official, analyzed Meng’s extradition case last May in the British Columbia Supreme Court in Vancouver as meeting the “double criminality” standard, arguing that the entire vaccine delivery fiasco was a deliberate attempt by China to pressure Canada and that the blame should be placed on the Chinese side.
BioNTech Laboratories in Mainz, Germany.
Recent Comments